Criteria for liver transplantation for hepatocellular carcinoma: What is an acceptable outcome?

Liver International

Volumn 31, Issue SUPPL. 1, 2011, Pages 161-163

  Belghiti, Jacques ^a   Durand, François ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Criteria; HCC; Liver transplantation

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; HUMAN; LIVER CELL CARCINOMA; LIVER NODULE; LIVER TRANSPLANTATION; PREDICTION; RISK FACTOR; TREATMENT INDICATION; TREATMENT OUTCOME;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PATIENT SELECTION; RECURRENCE; RISK FACTORS; SURVIVAL RATE;

EID: 78650824277     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02413.x     Document Type: Article

References (16)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-17.
2. Iwatsuki S, Gordon RD, Shaw BW, Jr, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 1985; 202: 401-7.
3. Dusheiko GM, Hobbs KE, Dick R, Burroughs AK. Treatment of small hepatocellular carcinomas. Lancet 1992; 340: 285-8.
4. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-9.
5. Duffy JP, Vardanian A, Benjamin E, et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22 year experience with 467 patients at UCLA. Ann Surg 2007; 246: 502-9.
6. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403.
7. Onaca N, Davis GL, Goldstein RM, Jennings LW, Klintmalm GB. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the international registry of hepatic tumors in liver transplantation. Liver Transpl 2007; 13: 391-9.
8. Silva M, Moya A, Berenguer M, et al. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Liver Transpl 2008; 14: 1449-60.
9. Yao FY. Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria. Am J Transpl 2008; 8: 1982-9.
10. Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35-43.
11. Vivarelli M, Dazzi A, Zanello M, et al. Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. Transplantation 2010; 89: 227-31.
12. Plessier A, Codes L, Consigny Y, et al. Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma. Liver Transpl 2004; 10 (2 Suppl. 1): S86-90.
13. Toso C, Asthana S, Bigam DL, et al. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology 2009; 49: 832-8.
14. Llovet JM, Mas X, Aponte JJ, et al. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut 2002; 50: 123-8.
15. Belghiti J, Cortes A, Abdalla EK, et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003; 238: 885-92.
16. Irtan S, Francoz C, Durand F, et al. Liver transplantation for HCC: towards zero percent recurrence rate in patients within the Milan criteria. Liver Transplant 2010; 16 (Suppl.1): S69.